Skip to main content

Ulcerative Colitis - Maintenance News (Page 2)

FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira

Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a p...

FDA Approves Renflexis (infliximab-abda), a Biosimilar to Remicade

INCHEON, Korea – April 24, 2017 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Renflexis (infliximab-abda), a biosimilar referencing Rem...

FDA Approves Amjevita (adalimumab-atto), a Biosimilar to Humira

September 23, 2016 – The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. Amjevita is approved...

FDA Approves Uceris (budesonide) Rectal Foam for Ulcerative Colitis

RALEIGH, N.C., October 8, 2014 – Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration (FDA) has granted final approval for Uceris (budesonide) rectal foam...

FDA Approves Simponi to Treat Ulcerative Colitis

May 15, 2013 – The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis. Simponi works by blocking...

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol

DUBLIN, Ireland, Feb. 5, 2013 – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the...

Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis

Lialda has been indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and is now also approved for the maintenance of remission of ulcerative colitis ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Ulcerative Colitis

Related drug support groups

Remicade